Classification of Macular Hemorrhages
Several therapeutic strategies are available for the treatment of submacular hemorrhages. The key points for choosing the appropriate therapy are (1) the underlying pathology, commonly a choroidal neovascular membrane (CNVM), especially in AMD patients, followed by non-AMD-related CNVM and retinal arterial macroaneurysms (RAM) and (2) the extent and location of the hemorrhage including size, thickness, and location in relation to the fovea and the layer in which the blood is present. We suggest a classification to be used for clinical decision-making and also in future studies when comparing efficacy of different treatment strategies for macular hemorrhage. This classification considers the size and extent, thickness, and the retinal layers involved.
KeywordsMacular hemorrhage Classification Size Sub-RPE Subretinal Age-related macular degeneration Retinal macroaneurysm
- 2.Hohn F, Mirshahi A, Hattenbach LO. [Combined intravitreal injection of bevacizumab and SF6 gas for treatment of submacular hemorrhage secondary to age-related macular degeneration]. Ophthalmologe. 2010;107(4):328–32.Google Scholar
- 3.Nakamura H, Hayakawa K, Sawaguchi S, Gaja T, Nagamine N, Medoruma K. Visual outcome after vitreous, sub-internal limiting membrane, and/or submacular hemorrhage removal associated with ruptured retinal arterial macroaneurysms. Graefes Arch Clin Exp Ophthalmol. 2008;246(5):661–9.CrossRefPubMedPubMedCentralGoogle Scholar
- 4.Agostini HT, Bopp S, Feltgen N. [Prognosis and treatment of macular bleeding in neovascular age-related macular degeneration]. Ophthalmologe. 2017;114(5):476–80.Google Scholar
- 15.Stopa M, Kociecki J. [Macular translocation with 360 retinectomy for submacular hemorrhage in age related macular degeneration]. Klin Oczna. 2009;111(1–3):50–5.Google Scholar